Medical research

Understanding the progress of viral infections

It is only 120 millionths of a millimeter in size but can bring entire countries to a standstill: the Corona virus. Even if it were to disappear one day, viral infections will still be among the most frequent and difficult-to-treat ...

Medications

Gilead seeks FDA approval for remdesivir

(HealthDay)—Gilead Sciences has applied to the U.S. Food and Drug Administration for approval for its COVID-19 treatment, remdesivir. The antiviral drug will take the brand name Veklury, the company said.

Diseases, Conditions, Syndromes

Experts make weak recommendation for remdesivir in severe COVID-19

In The BMJ today, a panel of international experts make a weak recommendation for the use of remdesivir in patients with severe covid-19, and strongly support continued enrolment of patients into ongoing clinical trials of ...

Pediatrics

The parenting myth revealed by lockdown

On Thursday, March 26 this year, working parents faced a dilemma—how were they going to work and care for their children during lockdown? The restrictions meant schools, early childcare centres, and kindergartens were closed. ...

Medications

Gilead's $2,340 price for coronavirus drug draws criticism

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other ...

Cardiology

Every heart dances to a different tune

Play the same piece of music to two people, and their hearts can respond very differently. That's the conclusion of a novel study presented today on EHRA Essentials 4 You, a scientific platform of the European Society of ...

page 6 from 12